news
Researchers have identified that MHC Class I-high, CDK1 high molecules…
15 October 2018 | By Dr Zara Kassam (Drug Target Review)
Researchers have identified that MHC Class I-high, CDK1 high molecules may be at the heart of conditions including melanoma, pancreatic and colon cancers...